Here are five more supply chain updates from the last week:
1. The potential strike of 22,000 dockworkers along the nation’s West Coast could exacerbate current supply shortages and lead to higher prices for consumer goods.
2. The U.S. is halting distribution of sotrovimab, a COVID-19 antibody made by GlaxoSmithKline and Vir Biotechnology, in regions where the omicron subvariant BA.2 has become dominant after data suggested the treatment is ineffective against the strain.
3. A congressional oversight subcommittee opened an investigation into the FDA’s regulation of the HeartWare Ventricular Assist Device after the agency identified safety issues with the heart pump that’s been implanted into thousands of Americans..
4. Independent scientific organization U.S. Pharmacopeia released a medicine supply map aiming to build visibility and identify which pharmaceutical ingredients are vulnerable to shortages.
5. The FDA shared recommendations for healthcare organizations to conserve prefilled 0.9 percent sodium chloride intravenous lock/flush syringes amid a national shortage.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
